Hello <<First Name>>!

This week's newsletter includes a summary of the latest health-technology and funding news, upcoming Health-Tech events and more.

In this weeks newsletter we touch on a variety of topics, including: 

  • New innovative ways to combat coronavirus
  • DNA tests and the current market 
  • Take part in our AI healthcare outcomes poll on twitter
Plus much more! 

A reminder, Super Early Bird tickets for GIANT Health 2020 are now on sale. We don't want you to miss out on this amazing discount. Head over to our website to purchase and save over £800. Feel free to let us know when you do.  

Don't hesitate to ask for more information!

Barry Shrier, Founder, GIANT Health
+44 7776 132 517

PS: We are always on the lookout for talent, we're recruiting for a number of positions, view our latest roles here


How is digital health being used to fight back against Coronavirus?  

Artificial Intelligence (AI) powered chatbots have been used to screen people for coronavirus. Currently, the chatbots have revealed a large number of people with the flu. Which is probably reasonable considering the fact it is flu season. One company 98point6 managed to highlight two patients, however, it was not deemed necessary for them to isolated and/or referred for official testing. A positive that has been noted is the reassurance that these companies are apparently providing. With those, who would otherwise not, seeking treatment and help for their symptoms. 

In line with this the parent company Bespoke has launched an AI powered chatbot advisor Bebot to keep passengers informed about the coronavirus outbreak. The widespread notoriety of the outbreak, which has alrerady reached 28 countries, has been one of the key topics in the news. The application is a multilingual AI solution that aims to provide information based on the travel and tourism industry updates. With Bespoke's customers including Sendai International Airporrt, Tokyo Metro and Sofitel Hotels and Resorts. Read more. 

Significant slowdown in the consumer DNA-testing market 
Ancestry recently followed in the footsteps of 23andMe and decided to cut 6% of their workforce. With a spokesperson for Ancestry claiming that the decision "did not [come] lightly". With sales of consumer DNA tests slowing down it is thought that consumer privacy is one of the main driving factors. The cuts at Ancestry did not focus on a particular department. Staff from across several departments and disciplines, within the largest seller of at home DNA tests for health and genealogy, were let go. 

CEO and president, Margo Georgiadis, confirmed that there was a slow down in demand for home DNA kits. Especially, now that early adopters were, most likely, already onboard. This news comes weeks after 23andMe, their main competitor, announced that they were to lay-off 14% of their staff because of lower than expected sales. Moving forward, it's thought that: innovative products and a drive to build consumer trust; will be two of the key ways in which the DNA-testing market will grow. Read more

Click above to take part in our poll on twitter. 
Share Share
Tweet Tweet
Forward Forward


Iora Health €100M (U.S)
  • $100 million 💸
  • Series E Financing 
  • Global investors include .406 Ventures, Devonshire Investors, F-Prime Capital, GE Ventures and others
Iora Health, a Boston-based, primary care provider that serves U.S. patients with a relationship-based care model. It has been cited as delighting customers, improving health outcomes and reducing overall costs. 

The company doubled its number of patients last year and have projected this happening again in 2020. Iora Health's care model focuses on relationships to improve health outcomes. With care teams that include: Health Coaches, Behavioural health Specialists, Team nurses, Clinical Team managers and Operational assistants. CEO and Co-Founder of Iora Health Rushika Fernandopulle has said they aim to continue to "deliver [their] high quality care to more patients in new and existing markets," with the investment.  

Nurvv secures funding (U.K.)
  • $9 million 💸
  • Series A 
  • Led by Hiro Capital

Nurvv, is a London based, biomechanics and wearables startup. The company is led by husband and wife Jason and Ulrica Roberts who founded this startup and Tech21. The patented smart insoles, coupled with an app, give runners real-time technical coaching. With data being fed into the corresponding coaching app for a holistic picture of the wearer's running technique. 

The company claims to use actionable insights to be able to deliver a unique and personalised experience. They intend to use the funds to accelerate the launch of 'NURVV' as a product to a worldwide market. They are also hoping to expand their patented biomechanics sensor tech into sports, games and wellness.  

GIANT Health's "5000 Women" Campaign 
You may recall we announce the GIANT Health 5000 woman campaign a couple of weeks ago. Well they would like all of the amazing women in the community to get involved. 

"To all the amazing women in healthcare, what would you like to see in our GIANT "5000 Women" Campaign 2020? Email us at and support our cause for a greater future for the womenkind. We would love to hear from you and don't forget, more tickets to GIANT Health  are on sale! 
Click below for more information

Gill Jennings & Every (GJE) - is a leading intellectual property firm based in London and Munich. Consistently recognised by the leading UK legal directories as a “go-to” firm, GJE has specialist patent, design and trademark attorneys who are able to advise across the full range of intellectual property rights. GJE’s specialist Health Tech group assists Health Tech companies of all sizes to develop a tailored IP strategy to protect, exploit and manage their IP assets to maximise their commercial value.
Want to know more about GJE's services contact them here

Reasons to be cheerful, Part 3:

World Cancer day was just last week on the 4th February. If you head over to you can read some of the most inspiring global stories

GIANT Health Event 

GIANT Health 2019 - Highlight reel
GIANT Health reaches thousands of members of the global HealthTech community. Get in touch to discuss partnership opportunities. 

Barry Shrier, Founder, GIANT Health
@Barry_HealthTec | +44 7776 132 517

PS: If you're recruiting, looking for a hospital trial partner, in fundraising mode, looking for a job...please get in touch and we'll be happy to support you in this newsletter. 
GIANT would like to thank our sponsors for their support, you guys are great!
We are writing to you because we consider you a valuable member of the global health tech community.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
GIANT Health Event · 1-6 Speedy Place · Cromer Street · London, London WC1H 8BS · United Kingdom